Tolerogenic maturation of liver sinusoidal endothelial cells promotes B7-homolog 1-dependent CD8+ T cell tolerance

被引:231
作者
Diehl, Linda [1 ]
Schurich, Anna [1 ]
Grochtmann, Regina [1 ]
Hegenbarth, Silke [1 ]
Chen, Lieping [2 ]
Knolle, Percy A. [1 ]
机构
[1] Univ Hosp Bonn, Inst Mol Med & Expt Immunol, D-53129 Bonn, Germany
[2] Johns Hopkins Univ, Sch Med, Dept Dermatol & Oncol, Baltimore, MD USA
关键词
D O I
10.1002/hep.21965
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
capable of cross-presentation and subsequent tolerization of naive CD8(+) T cells. We investigated the molecular mechanisms underlying this tolerance induction in naive CD8(+) T cells. MHC class I-restricted antigen presentation by LSEC led to initial stimulation of naive CD8+ T cells, which up-regulated CD69, CD25, CD44, and programmed death (PD)-1 and proliferated similar to dendritic cell (DC)-activated CD8+ T cells. Importantly, cognate interaction with naive CD8(+) T cells triggered increased expression of co-inhibitory B7-H1 but not co-stimulatory CD80/86 molecules exclusively on LSEC but not DC. This matured phenotype of B7-H1 high CD80/86(low) was critical for induction of CD8(+) T cell tolerance by I-SEC: B7-H1-deficient LSEC, that failed to interact with PD-1 on stimulated T cells, were incapable of inducing CD8+ T cell tolerance. Moreover, increased costimulation via CD28 interfered with tolerance induction, indicating that the noninducible low expression levels of CD80/86 on LSEC supported B7-H1-dependent tolerance induction. LSEC-tolerized CD8+ T cells had a distinctive phenotype from naive and activated T cells with CD25(low), CD44(high), CD62L(high). They also expressed the homeostatic cytokine receptors CD127, CD122, and high levels of Bcl-2, indicating survival rather than deletion of tolerant CD8(+) T cells. On adoptive transfer into congenic animals, tolerized CD8(+) T cells failed to show specific cytotoxicity in vivo. Conclusion: Cognate interaction of LSEC with naive CD8(+) T cells elicits a unique tolerogenic maturation of LSEC and permissiveness of T cells for tolerogenic signals, demonstrating that I-SEC-induced tolerance is an active and dynamic process.
引用
收藏
页码:296 / 305
页数:10
相关论文
共 48 条
  • [1] Dendritic cells and the control of immunity
    Banchereau, J
    Steinman, RM
    [J]. NATURE, 1998, 392 (6673) : 245 - 252
  • [2] Restoring function in exhausted CD8 T cells during chronic viral infection
    Barber, DL
    Wherry, EJ
    Masopust, D
    Zhu, BG
    Allison, JP
    Sharpe, AH
    Freeman, GJ
    Ahmed, R
    [J]. NATURE, 2006, 439 (7077) : 682 - 687
  • [3] Cross-presentation of antigens from apoptotic tumor cells by liver sinusoidal endothelial cells leads to tumor-specific CD8+ T cell tolerance
    Berg, Martina
    Wingender, Gerhard
    Djandji, Dominik
    Hegenbarth, Silke
    Momburg, Frank
    Hämmerling, Guenter
    Limmer, Andreas
    Knolle, Percy
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2006, 36 (11) : 2960 - 2970
  • [4] Bertolino P, 1998, EUR J IMMUNOL, V28, P221, DOI 10.1002/(SICI)1521-4141(199801)28:01<221::AID-IMMU221>3.3.CO
  • [5] 2-6
  • [6] A key role for ICAM-I in generating effector cells mediating inflammatory responses
    Camacho, SA
    Heath, WR
    Carbone, FR
    Sarvetnick, N
    LeBon, A
    Karlsson, L
    Peterson, PA
    Webb, SR
    [J]. NATURE IMMUNOLOGY, 2001, 2 (06) : 523 - 529
  • [7] CTLA-4-mediated inhibition in regulation of T cell responses: Mechanisms and manipulation in tumor immunotherapy
    Chambers, CA
    Kuhns, MS
    Egen, JG
    Allison, JP
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 2001, 19 : 565 - 594
  • [8] Hepatic T cells and liver tolerance
    Crispe, IN
    [J]. NATURE REVIEWS IMMUNOLOGY, 2003, 3 (01) : 51 - 62
  • [9] Signal 3 determines tolerance versus full activation of naive CD8 T cells: Dissociating proliferation and development of effector function
    Curtsinger, JM
    Lins, DC
    Mescher, MF
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (09) : 1141 - 1151
  • [10] Peripheral deletion of autoreactive CD8 T cells by cross presentation of self-antigen occurs by a Bcl-2-inhibitable pathway mediated by bim
    Davey, GM
    Kurts, C
    Miller, JFAP
    Bouillet, P
    Strasser, A
    Brooks, AG
    Carbone, FR
    Heath, WR
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (07) : 947 - 955